科达利(002850) - 2023 Q3 - 季度财报
KDLKDL(SZ:002850)2023-10-26 16:00

Financial Performance - The company's revenue for Q3 2023 reached ¥2,851,148,450.57, representing a 10.43% increase year-over-year, while the year-to-date revenue was ¥7,768,355,719.01, up 30.12% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2023 was ¥286,193,216.65, a 14.80% increase year-over-year, and the year-to-date net profit was ¥794,968,697.74, reflecting a 33.95% increase[3] - The basic earnings per share for Q3 2023 was ¥1.11, up 4.72% year-over-year, while the diluted earnings per share was also ¥1.11, marking a 4.72% increase[3] - Total operating revenue for the period reached CNY 7,768,355,719.01, a 30.1% increase from CNY 5,970,077,699.07 in the previous period[18] - Net profit for the period was CNY 805,554,206.06, compared to CNY 600,631,919.92 in the same period last year, representing a growth of 33.9%[21] - Earnings per share (EPS) increased to CNY 3.28 from CNY 2.54, indicating improved profitability on a per-share basis[21] - The company reported a comprehensive income total of CNY 814,242,169.23, up from CNY 579,786,557.93, highlighting overall financial health improvement[21] Assets and Liabilities - Total assets as of September 30, 2023, amounted to ¥17,364,784,279.11, a 22.51% increase from the end of the previous year[3] - The company's total liabilities decreased to CNY 7,181,489,102.32 from CNY 8,346,588,835.27, showing a reduction in financial leverage[19] - The company's equity attributable to shareholders reached ¥10,074,971,083.33, which is a 75.83% increase compared to the end of the previous year[3] - Total equity attributable to shareholders of the parent company rose to CNY 10,074,971,083.33, up from CNY 5,729,903,705.13, reflecting strong retained earnings growth[19] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥35,945,921.00, showing a decline of 25.58% compared to the previous year[3] - The total cash inflow from operating activities for the period was CNY 6,107,127,052.38, a significant increase from CNY 3,829,392,092.89 in the previous period, representing a growth of approximately 59.5%[22] - The net cash flow from operating activities was CNY 35,945,921.00, down from CNY 48,302,052.81 in the previous period, indicating a decrease of about 25.5%[22] - The cash inflow from investment activities totaled CNY 352,808,553.43, a decrease from CNY 1,956,802,782.86 in the previous period, reflecting a decline of approximately 82.0%[23] - The net cash flow from investment activities was -CNY 2,488,188,576.26, worsening from -CNY 1,869,258,170.69 in the previous period[23] - The cash inflow from financing activities was CNY 4,086,747,709.90, up from CNY 2,863,000,376.36 in the previous period, marking an increase of about 42.6%[23] - The net cash flow from financing activities was CNY 2,793,460,480.67, compared to CNY 2,344,692,680.04 in the previous period, showing an increase of approximately 19.1%[23] Inventory and Receivables - The company reported a significant increase in receivables financing, which rose by 127.15% to ¥2,374,422,464.77, attributed to an increase in bank acceptance bills and electronic debt instruments[6] - Inventory decreased by 25.96% to ¥918,376,094.02, indicating improved inventory turnover[6] - Accounts receivable increased to ¥2.85 billion from ¥2.83 billion, showing a slight growth of approximately 0.4%[15] - Inventory decreased to ¥918.38 million from ¥1.24 billion, reflecting a reduction of about 26%[15] Investments and Contracts - The company approved an investment of up to €30 million in its wholly-owned subsidiary in Germany for new production line construction and equipment purchase[12] - A supply contract was signed with a well-known European lithium battery manufacturer to provide approximately 350 million sets of square lithium-ion battery covers[11] - The company completed a private placement of 33,471,626 shares to 24 specific investors, approved by the China Securities Regulatory Commission in June 2023[10] Research and Development - Research and development expenses for the period were CNY 434,442,943.80, compared to CNY 396,288,404.59, indicating a continued investment in innovation[19]